Chemoinformaics analysis of 9,12-Octadecadienoic acid (Z,Z)-
| Molecular Weight | 280.452 | nRot | 14 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 3 |
| Exact Molecular Weight | 280.24 | nRing | 0 |
| Solubility: LogS | -5.23 | nHRing | 0 |
| Solubility: LogP | 6.652 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 53.0014 |
| nHD | 1 | BPOL | 32.9706 |
| QED | 0.318 |
| Synth | 2.292 |
| Natural Product Likeliness | 1.187 |
| NR-PPAR-gamma | 0.983 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.01 |
| CACO-2 | -4.733 |
| MDCK | 0.0000192 |
| BBB | 0.196 |
| PPB | 0.983907 |
| VDSS | 0.626 |
| FU | 0.0161861 |
| CYP1A2-inh | 0.235 |
| CYP1A2-sub | 0.171 |
| CYP2c19-inh | 0.086 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.43 |
| CYP2c9-sub | 0.988 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.086 |
| CYP3a4-inh | 0.085 |
| CYP3a4-sub | 0.019 |
| CL | 3.327 |
| T12 | 0.628 |
| hERG | 0.009 |
| Ames | 0.013 |
| ROA | 0.01 |
| SkinSen | 0.961 |
| Carcinogencity | 0.153 |
| EI | 0.98 |
| Respiratory | 0.712 |
| NR-Aromatase | 0.284 |
| Antiviral | Yes |
| Prediction | 0.571581 |